A Pharmaceuticals and Healthcare (Bulk Drug manufacturing) entity from India is looking to sellout.
Posted By - Investment Banker
Posted date - 18/02/2021
BUSINESS BRIEF
- Industry- Pharmaceuticals
- Subindustry- Bulk Drug Manufacturing
- Financial highlights-
|
Year |
Sales (in INR Million) |
|
2019 |
170 |
|
2020 |
191 |
- Business description
The Company is a WHO-GMP Certified Bulk drug manufacturing pharmaceutical company with a 1750Sq.Yard fully functional plant in Ahmedabad (having approvals with WHO-GMP, ISO, PPB Kenya ETC) capable of producing upto 70mn Tablets and capsules a month with a fail rate of <0.01%.Currently having 450+ products with core competency in Narcotic and psychotropic drugs and formulations.The company has a pan-india network for distribution and A 100% growth rate in the past two years.
Proposal
Industry
Pharmaceuticals
Sub Industry
Bulk Drug manufacturing
Deal Size
INR 50 - 55 Cr
Motives For Sellout
Sell Out
Management is open to continue with the business for handholding the new investor/buyers
Business Operation Information
Industry
Pharmaceuticals
Sub-Industry
Bulk Drug manufacturing
Division
Division`s Buyers/Customers
Financial Information |
2018 (in Cr) | 2019 (in Cr) | 2020 (in Cr) | 2021 (in Cr) |
|---|---|---|---|---|
Sales |
N.D | INR 17 Cr | INR 19.1 Cr | N.D |
EBITDA |
N.D | N.D | ||
PAT |
N.D | N.D | N.D | N.D |
TOTAL DEBT |
N.D | N.D | N.D | N.D |